Rabin Martin

  • Newsletter Sign-Up
  • Twitter
  • LinkedIn
Menu
  • HOME
  • OUR FIRM
    • About Us
    • Diversity & Inclusion
    • Job Openings
    • News
  • OUR WORK
    • Expertise
    • Case Studies
    • Our Clients
    • PSRT
    • SPARK
  • OUR PRODUCTS
    • LiGHT
  • TEAM
  • OUR INSIGHTS
    • Briefings
    • Blog
    • Reports
  • CONTACT US
  • NEWSLETTER SIGN-UP
  1. Rabin Martin | Ideas change health
  2. Our firm
  3. News
  4. Rabin Martin Launches Efforts against Chronic Disease at Clinton Global Initiative

Rabin Martin Launches Efforts against Chronic Disease at Clinton Global Initiative

27 September 2012
  • Email
  • Print
  • Plus
Rabin Martin Launches Efforts against Chronic Disease at Clinton Global Initiative
Rabin Martin President and CEO Bill Martin with former President Bill Clinton at the Clinton Global Initiative’s Annual Meeting in September. Photo courtesy of Paul Morse/Clinton Global Initiative

Rabin Martin launched a global advocacy program at the Clinton Global Initiative Annual Meeting to help address the challenges of non-communicable diseases (NCDs), including diabetes, heart disease and cancer, which together represent the greatest current threats to health.

“Collectively, NCDs represent a very serious issue for people all over the world, with a heavy burden in developing countries,” commented Rabin Martin Senior Partner Jeffrey L. Sturchio. “We are obviously pleased to be launching this new Commitment to Action through the Clinton Global Initiative and look forward to identifying new opportunities to address this growing challenge.”

Under this commitment, Rabin Martin will lead the development of expert recommendations on gaps in NCD research, policy and practice, with a focus on roles for partnerships and the private sector. The program stems from a collaborative effort with the Johns Hopkins University Institute of Applied Economics, Global Health and the Study of Business Enterprise, along with a working group of international experts, supported by a grant from the International Federation of Pharmaceutical Manufacturers & Associations.

The recommendations are expected to highlight opportunities for the private sector to address the challenges of NCDs in emerging markets and developing countries. Ultimately, the hope is to catalyze adoption of new approaches by companies, global health institutions and national governments.

Established in 2005 by President Bill Clinton, the Clinton Global Initiative (CGI) convenes global leaders to create and implement innovative solutions to the world’s most pressing challenges. CGI Annual Meetings have brought together more than 150 heads of state, 20 Nobel Prize laureates, and hundreds of leading CEOs, heads of foundations and NGOs, major philanthropists and members of the media. To date CGI members have made more than 2,300 commitments, which are already improving the lives of nearly 400 million people in more than 180 countries. When fully funded and implemented, these commitments will be valued at $73.5 billion.

  • Email
  • Print
  • Plus

Tags: cancer, cardiovascular, Clinton Global Initiative, diabetes, Jeff Sturchio, lung disease, NCDs

  • Contact us
  • Privacy Policy
  • Twitter
  • LinkedIn

All Rights Reserved Rabin Martin © 2022

Scroll up

Thanks for your interest!

Please just tell us a bit about yourself to download your requested report without delay.

Fields with * are mandatory.

We respect your privacy